14158 Results (Page 436 of 567)
All Market Research Reports
Thailand Cardiac Surgery Instruments Market Analysis
The Thailand Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 6.94% for the forecasted year 2022-2030. Thailand has an advantageous business climate due to its friendly government policies, affordable labour, and competent labour force. As a result, many manufacturers have established operations in the country to take advantage of the expanding market for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Xovic, Meticuly, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Tanzania Cardiac Surgery Instruments Market Analysis
The Tanzania Cardiac Surgery Instruments Market is expected to witness growth from $0.8 Mn in 2022 to $1.5 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-2030. Tanzania has a significant incidence and prevalence of ischemic heart disease and rheumatic heart disease. The country's demand for cardiac surgery instruments is anticipated to increase due to the rising prevalence of these illnesses. The market is segmented by type, application and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
South Africa Cardiac Surgery Instruments Market Analysis
The South Africa Cardiac Surgery Instruments Market is expected to witness growth from $13 Mn in 2022 to $25 Mn in 2030 with a CAGR of 7.83% for the forecasted year 2022-2030. Increase in the prevalence of Coronary Artery Disease (CAG) in South Africa. As more patients need surgical procedures to control their conditions, this is increasing demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Singapore Cardiac Surgery Instruments Market Analysis
The Singapore Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. Cardiovascular conditions such as coronary artery disease, heart failure, and arrhythmias are becoming more prevalent in Singapore due to factors such as the ageing population, sedentary lifestyles, and unhealthy diets. As a result, there is now greater demand for the tools and techniques used in heart surgery. The market is segmented by type, application and by end user. Some key players in this market include Biosensors International, Inzign Pte, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Saudi Arabia Cardiac Surgery Instruments Market Analysis
The Saudi Arabia Cardiac Surgery Instruments Market is expected to witness growth from $35 Mn in 2022 to $66 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Saudi Arabia, the incidence of cardiovascular diseases such as coronary heart disease, stroke, and hypertension is rising. In order to diagnose, treat, and control these conditions, cardiac surgery equipment is in high demand. The market is segmented by type, application and by end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Romania Cardiac Surgery Instruments Market Analysis
The Romania Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $10 Mn in 2030 with a CAGR of 6.85% for the forecasted year 2022-2030. Patients from different countries are travelling to Romania for cardiac surgeries, making it an increasingly popular location for medical tourism. The demand for high-quality cardiac surgery instruments is expected to increase as a result of this tendency. The market is segmented by type, application and by end user. Some key players in this market include BioSintex, Trident Medical Company S.R.L, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Poland Cardiac Surgery Instruments Market Analysis
The Poland Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 7.05% for the forecasted year 2022-2030. Cardiovascular diseases are becoming more prevalent in Poland as the country's populace increases. Additionally, the older population has more complicated health problems, which increases the demand for cardiac surgery instruments in Poland. The market is segmented by type, application and by end user. Some key players in this market include Metrum Cryoflex, Skamex, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Nigeria Cardiac Surgery Instruments Market Analysis
The Nigeria Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $3 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The market for instruments used in cardiac surgery is significantly influenced by the elevated rate of heart disease in Nigeria. The market is segmented by type, application and by end user. Some key players in this market include JNC International, GBioMed Nigeria, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Netherlands Cardiac Surgery Instruments Market Analysis
The Netherlands Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $9 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-2030. The demand for cardiac surgery instruments is anticipated to rise in the Netherlands as a result of a growing elderly population and the rising incidence of cardiovascular illnesses. The market is segmented by type, application and by end user. Some key players in this market include Hy2Care B.V, InnoSer, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Mexico Cardiac Surgery Instruments Market Analysis
The Mexico Cardiac Surgery Instruments Market is expected to witness growth from $31 Mn in 2022 to $53 Mn in 2030 with a CAGR of 6.85% for the forecasted year 2022-2030. Heart failure and coronary artery disease are two rising health concerns in Mexico. The overall incidence of these illnesses is anticipated to rise as the population grows and lifestyles change, fueling demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Malaysia Cardiac Surgery Instruments Market Analysis
The Malaysia Cardiac Surgery Instruments Market is expected to witness growth from $3 Mn in 2022 to $6 Mn in 2030 with a CAGR of 6.80% for the forecasted year 2022-2030. Malaysia is a common place for medical tourism because it has so many top-notch medical facilities and professionals, this is predicted to raise demand for cutting-edge medical equipment and technology, such as that used in cardiac surgery. The market is segmented by type, application and by end user. Some key players in this market include GA2 Medical, Transmedia Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Belgium Cardiac Surgery Instruments Market Analysis
The Belgium Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $8 Mn in 2030 with a CAGR of 6.60% for the forecasted year 2022-2030. The demand for cardiac surgery tools is rising in Belgium as cardiac diseases are becoming more common. The need for cardiac surgery instruments is expected to increase as the population ages and risk factors like smoking and obesity become more common in Belgium. The market is segmented by type, application and by end user. Some key players in this market include Trasis, Acertys Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Spain Cardiac Surgery Instruments Market Analysis
The Spain Cardiac Surgery Instruments Market is expected to witness growth from $40 Mn in 2022 to $62 Mn in 2030 with a CAGR of 5.60% for the forecasted year 2022-2030. In Spain, more people can now afford better healthcare services, such as cardiac surgeries, attributed to increasing disposable income. This has led to a rise in the demand for cardiac surgery equipment, opening up business possibilities for manufacturers. The market is segmented by type, application and by end user. Some key players in this market include Medlumics, Devicare, Ekuore, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Japan Cardiac Surgery Instruments Market Analysis
The Japan Cardiac Surgery Instruments Market is expected to witness growth from $129 Mn in 2022 to $223 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-2030. Japan's population is ageing at one of the fastest rates in the world, which is anticipated to increase demand for instruments used in cardiac surgery since older people are more likely to develop cardiac diseases. The market is segmented by type, application and by end user. Some key players in this market include Terumo Corporation, Fukuda, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Germany Cardiac Surgery Instruments Market Analysis
The Germany Cardiac Surgery Instruments Market is expected to witness growth from $76 Mn in 2022 to $110 Mn in 2030 with a CAGR of 4.80% for the forecasted year 2022-2030. In Germany, coronary heart disease, heart failure, and atrial fibrillation are among the leading causes of morbidity and death. The demand for cardiac surgery equipment is anticipated to increase as these illnesses become more common in the German healthcare market. The market is segmented by type, application and by end user. Some key players in this market include KLS Martin, Aesculap AG, RZ Medizintechnik GmbH, LivaNova, B. Braun, Medline Industries and STILLE.
France Cardiac Surgery Instruments Market Analysis
The France Cardiac Surgery Instruments Market is expected to witness growth from $57 Mn in 2022 to $88 Mn in 2030 with a CAGR of 5.60% for the forecasted year 2022-2030. The market for heart surgical devices in France is expanding as less invasive techniques become more popular. Because they are less intrusive, these procedures have quicker recovery periods and fewer complications, which is encouraging both patients and healthcare professionals to use them more frequently. The market is segmented by type, application and by end user. Some key players in this market include Delacroix-Chevalier, Marquat, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Egypt Cardiac Surgery Instruments Market Analysis
The Egypt Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $11 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Egypt, cardiac conditions like coronary artery disease and heart failure are extremely prevalent. The need for the instruments used in these procedures is growing as a consequence of the rise in cardiac surgeries. The market is segmented by type, application and by end user. Some key players in this market include JK Medirise, EGMED, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
US ECG Equipments Market Analysis
The US ECG equipment market is projected to grow from $3.7 Bn in 2022 to $5.7 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-2030. Cardiovascular Diseases (CVDs) are the leading cause of death in the United States, and ECG equipment is an essential tool for diagnosing these conditions. The rising prevalence of CVDs is driving the demand for ECG equipment. Some of the key players in the US ECG equipment market include GE Healthcare, Philips Healthcare, Nihon Kohden Corporation, Hill-Rom Holdings, Inc., and Schiller AG.
China Cardiac Surgery Instruments Market Analysis
The China Cardiac Surgery Instruments Market is expected to witness growth from $166 Mn in 2022 to $310 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In China, due to rising disposable income, more people in China can now access better healthcare services like cardiac surgeries. This has increased demand for cardiac surgery equipment, providing manufacturers with new business opportunities. The market is segmented by type, application and by end user. Some key players in this market include Lepu Medical Technology, MicroPort, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Canada Radiotherapy Market Analysis
Canada radiotherapy market is likely to grow at a CAGR of 6% from a market size of $552.8 Mn in 2022 to $881 Mn in 2030. The rising incidence of cancer and the technological advancements in radiotherapy acts as a market growth driver. This report is segmented by type, technology, application, and by end user. Some key players in this market include Siemens Healthineers, Elekta Accuray Incorporated, Hitachi, IsoRay, Zeiss group, and others.
Australia Cardiac Surgery Instruments Market Analysis
The Australian Cardiac Surgery Instruments Market is expected to witness growth from $25 Mn in 2022 to $46 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Australia, the demand for minimally invasive surgical instruments, like endoscopes and laparoscopic instruments, is anticipated to increase in the Australian healthcare market as patients there seek out less invasive surgical choices that reduce scarring and recovery time. The market is segmented by type, application and by end user. Some key players in this market include Fairmont Medical Products, Rowe Medical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Canada Liver Diseases Therapeutics Market Analysis
Canada's liver disease therapeutics market is likely to grow at a CAGR of 5.7% from a market size of $1.84 Bn in 2022 to $2.87 Bn in 2030. The increase in alcohol consumption along with the change in lifestyle and increasing geriatric population acts as a market growth driver. This report is segmented by treatment type, disease type, and by distribution channel. Some key players in this market include AbbVie, Novartis, Bristol-Myers & Squibb, Merck, Roche, Eli Lilly, and others.
Turkey Artificial Intelligence (AI) in Healthcare Market Analysis
Turkey's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.06 Bn in 2022 to $1.12 Bn by 2030, registering a CAGR of 45.72% during the forecast period of 2022 - 2030. The market will be driven by the country's growing demand for healthcare services and government initiatives to promote the use of AI in healthcare. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Hayriya & Mandarin Health.
Canada Cardiovascular Diseases Therapeutics Market Analysis
Canada's cardiovascular disease therapeutics market is likely to grow at a CAGR of 7.22% from a market size of $13.01 Bn in 2022 to $22.72 Bn in 2030. Rising cardiovascular disease prevalence and growing R&D are the major market driver. This report is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end users. Some key players in this market include Johnson and Johnson, Gilead, AstraZeneca, Novartis, Roche, Merck, Pfizer, and others.
Canada Cancer Immunotherapy Market Analysis
Canada's cancer immunotherapy market is likely to grow at a CAGR of 7.1% from a market size of $9 Bn in 2022 to $15.58 Bn in 2030. Rising cancer prevalence and growing adoption of immunotherapy are the major market driver. This report is segmented by type, application, and by distribution channel. Some key players in this market include Johnson and Johnson, Eli Lilly, Novartis, Roche, Merck, Pfizer, and others.
